Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Myelodysplastic Syndromes 11Leukemia, Myeloid, Acute 11Anemia, Refractory, with Excess of Blasts 10Leukemia 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Lymphoma 6Lymphoma, Non-Hodgkin 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4Hematologic Neoplasms 4Congenital Abnormalities 4Burkitt Lymphoma 4Blast Crisis 4Anemia, Refractory 4Primary Myelofibrosis 3Myeloproliferative Disorders 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Immunologic Deficiency Syndromes 3Histiocytosis 3Anemia, Sickle Cell 3Anemia, Aplastic 3Waldenstrom Macroglobulinemia 2Thrombocythemia, Essential 2

Interventions

fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Thiotepa 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Thiotepa × Classical hematology × Clear all
NCT04083170 2025-01-01

Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Fred Hutchinson Cancer Center

Phase 2 Terminated
1 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, HIV Infections, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡